Lincoln Pharma Share Price
Lincoln Pharma Share Price Today
As of 3 Sep 2026, Lincoln Pharma share price is ₹621.35. The stock opened at ₹627.35, compared to its previous close of ₹618.35. During today's trading session, Lincoln Pharma share price moved in the range of ₹620.05 to ₹627.35, with an average price of ₹623.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹440.00 and a high of ₹770.00. On the performance front, Lincoln Pharma share price has declined by 0.11% over the last six months and is up 11.19% on a year-on-year basis.
Lincoln Pharma Returns Calculator
About Lincoln Pharma
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.
Lincoln Pharma Financial Highlights
- Revenue: Lincoln Pharma reported revenue of ₹704.48 crore in FY26 vs ₹645.71 crore in FY25. It showed an increase of 9.10% on a yearly basis.
- Operating Profit: Lincoln Pharma reported an operating profit of ₹115.63 crore in FY26 vs ₹109.19 crore in FY25. It showed an increase of 5.90% on a year-on-year basis.
- Net Profit: Lincoln Pharma reported a net profit of ₹87.89 crore in FY26 vs ₹82.35 crore in FY25. It showed an increase of 6.73% on a yearly basis.
Lincoln Pharma Quarterly Result Highlights
- Lincoln Pharma reported revenue of ₹201.54 crore in Jun 2026, compared with ₹183.08 crore in Mar 2026, representing an increase of 10.08% on a quarter-on-quarter (QoQ) basis.
- Lincoln Pharma reported an operating profit of ₹47.55 crore in Jun 2026, compared with ₹16.70 crore in Mar 2026, representing an increase of 184.73% on a quarter-on-quarter (QoQ) basis.
- Lincoln Pharma reported a profit of ₹36.23 crore in Jun 2026, compared with ₹11.63 crore in Mar 2026, reflecting an increase of 211.52% on a QoQ basis.
- The earnings per share (EPS) of Lincoln Pharma stood at ₹41.11 during Jun 2026.
| Sep 2025 | 4.72% |
|---|---|
| Dec 2025 | 4.70% |
| Mar 2026 | 5.19% |
| Jun 2026 | 4.60% |
Lincoln Pharma Shareholder Returns
Lincoln Pharma Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,63,180.00 | 38.28 | 5.55 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,43,302.00 | 83.79 | 14.62 | 15.32% | 0.00 | 19.56% | 629.49 | 0.32% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,88,623.00 | 88.29 | 22.64 | 25.49% | 1.69 | 13.85% | 222.76 | 0.68% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,16,114.00 | 25.00 | 4.24 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Cipla | 1,14,554.00 | 34.02 | 3.32 | 11.27% | 0.00 | 14.95% | 423.36 | 0.92% | 0.45 | 43.52 |
| Laurus Labs | 1,00,660.00 | 92.32 | 18.99 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Lupin | 98,312.20 | 17.73 | 4.38 | 23.76% | 0.04 | 24.88% | 659.00 | 0.84% | 0.57 | 129.18 |
| Dr. Reddy's Laboratories | 96,906.30 | 30.44 | 2.55 | 11.07% | 0.18 | 12.54% | 377.95 | 0.69% | 0.41 | 38.68 |
| Mankind Pharma | 97,467.00 | 47.54 | 6.03 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Aurobindo Pharma | 96,836.10 | 25.68 | 2.52 | 9.25% | 0.19 | 11.76% | 394.82 | 0.24% | 0.38 | 41.58 |
Lincoln Pharma Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹623.23 | ₹580.55 | ₹510.31 | ₹472.12 |
| Other Income | ₹22.48 | ₹34.42 | ₹22.47 | ₹10.00 |
| Total Revenue | ₹645.71 | ₹614.97 | ₹532.78 | ₹482.12 |
| Total Expenses | ₹536.52 | ₹492.73 | ₹432.30 | ₹386.18 |
| Profit Before Tax | ₹109.19 | ₹122.24 | ₹100.48 | ₹95.94 |
| Tax | ₹26.84 | ₹28.94 | ₹27.58 | ₹26.58 |
| Profit After Tax | ₹82.35 | ₹93.30 | ₹72.90 | ₹69.36 |
| EPS - Basic | ₹41.11 | ₹46.58 | ₹36.40 | ₹34.63 |
| EPS - Diluted | ₹41.11 | ₹46.58 | ₹36.40 | ₹34.63 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹109.19 | ₹122.24 | ₹100.48 | ₹95.94 |
| Income before WC changes | ₹110.15 | ₹105.48 | ₹100.25 | ₹97.42 |
| Change in Assets | -₹12.20 | -₹37.43 | -₹13.13 | -₹10.97 |
| Change in Liabilities | ₹21.37 | ₹21.32 | -₹18.25 | ₹13.38 |
| Change in WC | ₹9.17 | -₹16.12 | -₹31.37 | ₹2.40 |
| Cash flow from Operations | ₹93.02 | ₹63.22 | ₹39.26 | ₹76.13 |
| Cash flow from Investing | -₹78.95 | -₹57.34 | -₹36.64 | -₹78.08 |
| Cash flow from Financing | -₹6.40 | -₹5.18 | -₹4.50 | -₹2.56 |
| Total Cash Flow | ₹7.67 | ₹0.70 | -₹1.88 | -₹4.50 |
| Cash (Start of the year) | ₹5.75 | ₹5.05 | ₹6.93 | ₹11.44 |
| Cash (End of the year) | ₹13.41 | ₹5.75 | ₹5.05 | ₹6.93 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹297.07 | ₹253.55 | ₹220.21 | ₹181.51 |
| Current Assets | ₹499.94 | ₹446.74 | ₹367.21 | ₹352.85 |
| Total Assets | ₹797.01 | ₹700.29 | ₹587.42 | ₹534.36 |
| Current Liabilities | ₹106.22 | ₹92.28 | ₹72.15 | ₹90.49 |
| Net Current Asset | ₹393.72 | ₹354.46 | ₹295.07 | ₹262.36 |
| Non-Current Liabilities | ₹19.12 | ₹15.18 | ₹12.80 | ₹10.99 |
| Equity Capital | ₹671.67 | ₹592.84 | ₹502.47 | ₹432.88 |
| Total Equity & Liabilities | ₹797.01 | ₹700.29 | ₹587.42 | ₹534.36 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹623.23 | ₹580.55 | ₹510.31 | ₹472.08 |
| Other Income | ₹22.48 | ₹34.42 | ₹22.48 | ₹10.00 |
| Total Revenue | ₹645.71 | ₹614.97 | ₹532.79 | ₹482.08 |
| Total Expenses | ₹536.52 | ₹492.73 | ₹432.34 | ₹386.15 |
| Profit Before Tax | ₹109.19 | ₹122.24 | ₹100.46 | ₹95.93 |
| Tax | ₹26.84 | ₹28.94 | ₹27.56 | ₹26.57 |
| Profit After Tax | ₹82.35 | ₹93.30 | ₹72.90 | ₹69.35 |
| EPS - Basic | ₹41.11 | ₹46.58 | ₹36.40 | ₹34.63 |
| EPS - Diluted | ₹41.11 | ₹46.58 | ₹36.40 | ₹34.63 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹109.19 | ₹122.24 | ₹100.46 | ₹95.93 |
| Income before WC changes | ₹110.15 | ₹105.49 | ₹100.17 | ₹97.42 |
| Change in Assets | -₹12.20 | -₹37.43 | -₹13.26 | -₹11.24 |
| Change in Liabilities | ₹21.37 | ₹21.32 | -₹18.15 | ₹13.65 |
| Change in WC | ₹9.17 | -₹16.12 | -₹31.40 | ₹2.40 |
| Cash flow from Operations | ₹93.02 | ₹63.24 | ₹39.16 | ₹76.18 |
| Cash flow from Investing | -₹78.95 | -₹57.34 | -₹36.64 | -₹78.08 |
| Cash flow from Financing | -₹6.40 | -₹5.18 | -₹4.50 | -₹2.56 |
| Total Cash Flow | ₹7.67 | ₹0.73 | -₹1.99 | -₹4.46 |
| Cash (Start of the year) | ₹5.31 | ₹4.58 | ₹6.57 | ₹11.03 |
| Cash (End of the year) | ₹12.97 | ₹5.31 | ₹4.58 | ₹6.57 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹297.12 | ₹262.56 | ₹220.26 | ₹181.56 |
| Current Assets | ₹499.75 | ₹437.59 | ₹367.00 | ₹352.56 |
| Total Assets | ₹796.87 | ₹700.15 | ₹587.26 | ₹534.11 |
| Current Liabilities | ₹106.08 | ₹92.14 | ₹71.98 | ₹90.24 |
| Net Current Asset | ₹393.67 | ₹345.45 | ₹295.02 | ₹262.31 |
| Non-Current Liabilities | ₹19.12 | ₹15.18 | ₹12.80 | ₹10.99 |
| Equity Capital | ₹671.67 | ₹592.84 | ₹502.47 | ₹432.88 |
| Total Equity & Liabilities | ₹796.87 | ₹700.15 | ₹587.26 | ₹534.11 |
| 3 Sep | 0L |
|---|---|
| 2 Sep | 0L |
| 1 Sep | 0L |
| 31 Aug | 0L |
| 28 Aug | 0L |
| 27 Aug | 0L |
| Average | 0L |
Popular Stocks
Lincoln Pharma Share Price FAQs
What is Lincoln Pharma share price today?
Lincoln Pharma share price is ₹621.35 as on 03 Sep, 2026, 09:42 IST.
How has the Lincoln Pharma share price performed in the past?
In the last 1 year, Lincoln Pharma delivered a return of 11.19%. The Lincoln Pharma share price hit a high of ₹770.00 and low of ₹440.00.
How much is the Mutual Fund shareholding in Lincoln Pharma shares?
The Mutual Fund Shareholding in Lincoln Pharma was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of Lincoln Pharma shares ?
The 52-week high and low of Lincoln Pharma share is ₹770.00 and ₹440.00 as of 03 Sep, 2026.
What is the market cap of Lincoln Pharma?
The market capitalisation of Lincoln Pharma is ₹1,223.22 Crores as on 03 Sep, 2026.
What are the stock symbols of Lincoln Pharma?
The stock symbol of Lincoln Pharma is LINCOLN on the NSE, 531633 on the BSE, and the ISIN is INE405C01035.
What was yesterday's closing price of Lincoln Pharma shares ?
Lincoln Pharma shares closed yesterday at ₹618.35 on NSE & ₹617.15 on BSE
How to buy Lincoln Pharma shares?
To buy Lincoln Pharma shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Lincoln Pharma shares on Holidays?
No, shares of Lincoln Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Lincoln Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Lincoln Pharma?
The PE and PB ratio of Lincoln Pharma is 12.82 and 1.63 respectively, as on 03 Sep, 2026, 09:42 IST.